LiraglutidevsMOTS-c
Liraglutide vs MOTS-c — independent comparison of uses, administration, pricing across providers, and key differences. Last reviewed April 21, 2026.
Quick Verdict
Based on clinical evidence and real patient data
A GLP-1 receptor agonist administered daily for chronic weight management. FDA-approved as Saxenda for obesity and as Victoza for type 2 diabetes. One of the first GLP-1 medications widely used for weight loss before semaglutide.
A mitochondria-derived peptide encoded within the mitochondrial genome. MOTS-c regulates metabolic homeostasis, enhances insulin sensitivity, and has shown promise in extending healthspan in animal studies. Levels naturally decline with age.
Best choice depends on your insurance, budget, and treatment history.Take the quiz to get a personalized recommendation.
Liraglutide vs MOTS-c: At a Glance
Full comparison across all key factors.
| Factor | LiraglutideALLY PICK | MOTS-c |
|---|---|---|
| Category | weight-loss | anti-aging |
| Also Known As | Saxenda, Victoza | Mitochondrial Open Reading Frame of the 12S rRNA-c |
| Administration | Subcutaneous injection (daily) | Subcutaneous injection |
| Prescription | Required | Required |
| Providers | 4 providers✓ Better | 2 providers |
| Common Uses |
|
|
Data sourced from FDA prescribing information and peer-reviewed clinical trials. Prices reflect telehealth platform costs as of April 21, 2026. See our methodology.
Pricing by Provider
1 provider offers both Liraglutide and MOTS-c.
| Provider | Liraglutide | MOTS-c | Consultation | Lab Testing |
|---|---|---|---|---|
 | $220/monthly | $220/monthly | Video Telehealth | Yes |
 | $299/monthly | Not offered | Video Telehealth | Yes |
 | $250/monthly | Not offered | Video Telehealth | Yes |
 | $200/monthly | Not offered | Video Telehealth | No |
 | Not offered | $280/monthly | Video Telehealth | Yes |
Key Differences
Liraglutide
More ProvidersA GLP-1 receptor agonist administered daily for chronic weight management. FDA-approved as Saxenda for obesity and as Victoza for type 2 diabetes. One of the first GLP-1 medications widely used for weight loss before semaglutide.
MOTS-c
A mitochondria-derived peptide encoded within the mitochondrial genome. MOTS-c regulates metabolic homeostasis, enhances insulin sensitivity, and has shown promise in extending healthspan in animal studies. Levels naturally decline with age.
Which Is Right for You?
Choose Liraglutideif…
- You want a weight-loss medication
- You prefer subcutaneous injection (daily) administration
- You want more provider options (4 available)
- Your primary goal is weight loss
- Your primary goal is appetite suppression
Choose MOTS-cif…
- You want a anti-aging medication
- You prefer subcutaneous injection administration
- 2 providers available on our platform
- Your primary goal is metabolic health
- Your primary goal is insulin sensitivity
Frequently Asked Questions
What is the difference between Liraglutide and MOTS-c?
Which is cheaper, Liraglutide or MOTS-c?
Can I switch from Liraglutide to MOTS-c?
Medical Disclaimer
This comparison is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual results may vary. The information presented reflects publicly available data and may not account for your specific health situation.
Related Guides
Generic Liraglutide (Saxenda Generic): The Budget GLP-1 Nobody's Talking About
Generic liraglutide from Teva is the first generic GLP-1 for weight loss. At ~$230/month, is it a viable budget alternative to semaglutide and orforglipron? Complete pricing and comparison guide.
Read guide →